Japanese encephalitis virus (JEV) strains can be separated into 5 genotypes (g1 to g5) based on sequence similarity. JEV g5 strains have been rarely isolated and are poorly characterized. We report here the full characterization of a g5 virus generated using a cDNA-based technology and its comparison with a widely studied g3 strain. We did not observe any major differences between those viruses when their infectious cycles were studied in various cell lines in vitro. Interestingly, the JEV g5 strain was highly pathogenic when inoculated to BALB/c mice, which are known to be largely resistant to JEV g3 infection. The study of chimeric viruses between JEV g3 and g5 showed that there was a poor viral clearance of viruses that express JEV g5 structural proteins in BALB/c mice blood, which correlated with viral invasion of the central nervous system and encephalitis. In addition, using an in vitro model of the blood-brain barrier, we were able to show that JEV g5 does not have an enhanced capacity for entering the central nervous system, compared to JEV g3. Overall, in addition to providing a first characterization of the understudied JEV g5, our work highlights the importance of sustaining an early viremia in the development of JEV encephalitis.
IMPORTANCEGenotype 5 viruses are genetically and serologically distinct from other JEV genotypes and can been associated with human encephalitis, which warrants the need for their characterization. In this study, we characterized the in vitro and in vivo properties of a JEV g5 strain and showed that it was more neuropathogenic in a mouse model than a well-characterized JEV g3 strain. The enhanced virulence of JEV g5 was associated with poor viral clearance but not with enhanced crossing of the blood-brain barrier, thus providing new insights into JEV pathogenesis. JEV is a significant human pathogen and the causative agent for Japanese encephalitis, one of the most important viral encephalitides of medical interest in Asia, with an incidence of approximately 67,900 cases per year, among which are about 20,000 fatal cases (1). About 20 to 30% of the symptomatic human cases are fatal, while 30 to 50% of survivors can develop long-term neurological sequelae (2). JEV is maintained in an enzootic cycle between Culex tritaeniorhynchus mosquitoes and amplifying vertebrate hosts, such as water birds and domestic swine (3). Humans and several other animals can also be infected, but since they do not develop a sufficient level of viremia to infect mosquitoes, they are thought to be dead-end hosts (4).Phylogenetic studies based on the viral envelope protein sequences allow the division of JEV strains into five genotypes (g1 to g5). From the isolation of the prototype strain of JEV in 1935 until recently, most of the circulating strains of JEV belonged to g3 and were at the origin of major epidemics in Southeast Asian countries (5). Recently, a shift in prevalence from JEV g3 to g1 has been observed in several Asian countries (6-8), while some strains of JEV g5 have been occasio...